Vogeley K T, Bilzer T, Reifenberger G, Wechsler W
Abteilung für Neuropathologie, Heinrich-Heine-Universität, Düsseldorf, Federal Republic of Germany.
Acta Neuropathol. 1991;82(1):78-85. doi: 10.1007/BF00310927.
The expression of glial fibrillary acidic protein (GFAP), vimentin, S-100 protein (S-100), HNK-1, myelin basic protein (MBP) and fibronectin was investigated immunohistochemically in 51 ethylnitrosourea (ENU)-induced neurinomas of the rat. Additionally, 90 transplantation tumors derived from ENU-induced neurinomas and the RN6 rat neurinoma cell clone were studied. Vimentin immunoreactivity was shown in 50/51 primary neurinomas and 60/90 transplantation tumors. In contrast, GFAP was expressed in only 23/51 primary tumors and in 5/90 transplantation tumors. In the RN6 neurinoma clone, vimentin and GFAP could be demonstrated both in vivo and in vitro. GFAP expression varied depending on the tumor localization, i.e., tumors of distal portions of peripheral nerves were more frequently GFAP positive than tumors of the spinal roots or of cranial nerves. The same tendency was observed for S-100. In the series of transplantation tumors S-100 and GFAP immunoreactivity decreased with increasing numbers of transplantation passages. Only individual cells in 5 primary tumors were HNK-1 positive and no MBP-immunoreactive cells were observed. Our results demonstrate that the expression of differentiation antigens in ENU-induced experimental neurinomas parallels the results reported for human neurinomas.
采用免疫组织化学方法研究了51例乙基硝基脲(ENU)诱导的大鼠神经鞘瘤中胶质纤维酸性蛋白(GFAP)、波形蛋白、S-100蛋白(S-100)、HNK-1、髓鞘碱性蛋白(MBP)和纤连蛋白的表达情况。此外,还研究了90例源自ENU诱导的神经鞘瘤的移植瘤以及RN6大鼠神经鞘瘤细胞克隆。波形蛋白免疫反应性在50/51例原发性神经鞘瘤和60/90例移植瘤中显示。相比之下,GFAP仅在23/51例原发性肿瘤和5/90例移植瘤中表达。在RN6神经鞘瘤克隆中,波形蛋白和GFAP在体内和体外均可检测到。GFAP的表达因肿瘤定位而异,即外周神经远端部分的肿瘤比脊髓神经根或颅神经肿瘤更频繁地呈GFAP阳性。S-100也观察到相同趋势。在移植瘤系列中,S-100和GFAP免疫反应性随着移植传代次数的增加而降低。5例原发性肿瘤中只有个别细胞HNK-1呈阳性,未观察到MBP免疫反应性细胞。我们的结果表明,ENU诱导的实验性神经鞘瘤中分化抗原的表达与人类神经鞘瘤的报道结果相似。